Oisin Biotechnologies Competitors and Similar CompaniesClear all

Oisin Biotechnologies's competitors and similar companies include Just-Evotec Biologics, Alembic Pharmaceuticals, UCB and Genentech.

	Oisin Biotechnologies Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat age-related diseases.	Just-Evotec Biologics Just-Evotec Biologics is an integrated design company focused on the technology of biotherapeutics.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
Founding Date	Founding Date 2014	Founding Date 2014	Founding Date 2010	Founding Date 1928	Founding Date 1976
Type	Type Private	Type Private	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare bioengineering biotech	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Seattle, US HQ Seattle, US	Locations Seattle, US HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more
Employees	Employees 17	Employees 6402% increase	Employees 14,858	Employees 9,052	Employees 18,077
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $20m (Y, 2018)	Revenue (est.) ₹73.4b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)	Gross profit €7.2b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income ₹6.7b (FY, 2026)	Net income €1.6b (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round $ 5m (almost 5 years ago)	Latest funding round $ 14m (almost 10 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A
Total funding raised	Total funding raised $ 5m	Total funding raised $ 29m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A